Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
about
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.Solid lipid nanoparticles for ocular drug delivery.Improvement of oral availability of ginseng fruit saponins by a proliposome delivery system containing sodium deoxycholateLipid-Based Drug Delivery Systems.Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal.Delivery of therapeutic proteins.Biomagnetic methods: technologies applied to pharmaceutical research.Insights on novel particulate self-assembled drug delivery beads based on partial inclusion complexes between triglycerides and cyclodextrins.Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.Preparation and Characterization of Self-Microemulsifying Drug Delivery System of Olmesartan Medoxomil for Bioavailability Improvement.Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation.Self-Nanoemulsifying Drug Delivery System for Resveratrol: Enhanced Oral Bioavailability and Reduced Physical Fatigue in Rats.Design and development of a self-nanoemulsifying drug delivery system for telmisartan for oral drug delivery.Self nanoemulsifying drug delivery system of stabilized ellagic acid-phospholipid complex with improved dissolution and permeabilitySelf-nanoemulsifying drug-delivery system for improved oral bioavailability of rosuvastatin using natural oil antihyperlipdemic.Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution.The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems.Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability.Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.Oral naringenin nanocarriers: Fabrication, optimization, pharmacokinetic and chemotherapeutic efficacy assessments.New lipid formulation of octenidine dihydrochloride.Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets.In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performancePharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble DrugsA novel and facile liquid whistle hydrodynamic cavitation reactor to produce submicron multiple emulsions
P2860
Q26744835-4C5E707A-1C44-4FF7-9ED8-4A69833CEED0Q34116807-E59C089F-B665-4144-A361-3A2BC14B5825Q35917912-D9373F1D-BEBF-4D82-9D1D-4976E1B30C91Q36112195-E56DDC7A-507E-47C9-A277-0670877BA3BBQ36148640-730CDC03-F18D-4007-8FFE-4645B72A5C4DQ37668486-B2BEF8F0-58E8-45F7-8031-DD6BE6A5B748Q37800414-EF487C12-C79C-45BB-AFBD-5DA4EA5D80FCQ38246043-9E3C6F97-F6B2-4530-A267-2BF5CC6A3A10Q38306645-0601ECE2-DDFD-44D9-9382-4BC67F679F17Q38967883-E674796B-0EA6-4D40-BB1D-F6DCE19A5EB2Q40335840-EC02A509-E774-4BC4-A75B-B01FAAE28736Q41201676-1832C173-3597-4087-B7F3-687B63A7D77EQ41661259-A006F7E4-461F-4530-8C9D-0361BB9F929EQ41895747-90393044-563E-4A16-9D91-0DDB241098BBQ42274166-33B34DF4-C92D-4F4E-8050-403C9B6F7C2EQ42697624-318353A7-542B-48AC-A5E8-480E90A77902Q45887220-CDCA80EA-F0D6-40CC-B886-D2CDBDE62E01Q45902882-50A8901F-8388-49EB-B3B4-AEC871DA063CQ46216605-51080A91-D6A8-4EC6-BDFC-1F3535B4CFBDQ50422486-140862CA-E04F-4338-9304-68DC68C7A5F6Q53485705-AB12ADE8-3CD7-42FC-B5F3-169FCFE4806FQ53615800-2433C010-E069-4C01-B258-B767F812E4FBQ54626013-A0797C03-ED6A-46C1-BEA1-F0CF26659E7EQ57815918-B3B42FC5-29D2-43D7-8159-BCD614A723EAQ58032213-668E281D-53D3-46AB-B383-3D6AB06DDBF9Q58920823-4AA55702-2E6D-4100-8955-E5F05323DB26
P2860
Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Lipid excipients and delivery ...... ent: a regulatory perspective.
@en
Lipid excipients and delivery ...... ent: a regulatory perspective.
@nl
type
label
Lipid excipients and delivery ...... ent: a regulatory perspective.
@en
Lipid excipients and delivery ...... ent: a regulatory perspective.
@nl
prefLabel
Lipid excipients and delivery ...... ent: a regulatory perspective.
@en
Lipid excipients and delivery ...... ent: a regulatory perspective.
@nl
P1476
Lipid excipients and delivery ...... ent: a regulatory perspective.
@en
P2093
Mei-Ling Chen
P304
P356
10.1016/J.ADDR.2007.09.010
P407
P577
2007-11-12T00:00:00Z